Drug Discovery And Development

4 researchers across 4 institutions

4 Researchers
4 Institutions
0 Grant PIs
0 High Impact

Research in drug discovery and development focuses on identifying and creating new therapeutic agents to treat diseases. This involves understanding disease mechanisms at a molecular level, designing and synthesizing novel chemical compounds, and evaluating their efficacy and safety. Investigations include exploring the structures and dynamics of biological molecules, employing advanced molecular modeling techniques, and utilizing nanoparticles for targeted drug delivery. The ultimate goal is to translate fundamental scientific understanding into new medicines.

This work holds potential relevance for Arkansas by addressing public health needs and fostering economic growth in the biotechnology and pharmaceutical sectors. Developing new treatments for prevalent diseases can improve the well-being of state residents. Furthermore, advancements in drug discovery can stimulate innovation and create opportunities for skilled jobs within Arkansas’s growing life sciences industry.

This research area benefits from strong interdisciplinary connections, drawing on expertise in protein structure, molecular biology, disease mechanisms, and materials science. Engagement across multiple institutions within Arkansas ensures a broad base of knowledge and collaborative potential.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Rahul Yadav University of Arkansas – Fort Smith 15 586 Faculty
Haarika Ayyadevara University of Arkansas 2 36
L.P.F. Balapiti-Modarage UAMS 2 201
Benjamin Rougeau Arkansas State University 2 46

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
2,984 works in 2026
-6.4% CAGR 2018–2026
Leadership concentration
1.9% held by global top 5 institutions
Fragmented HHI 2
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2026 window.

Top US institutions in this area

  1. 1 Kenyon College 1,387
  2. 2 University of Michigan 541
  3. 3 National Institutes of Health 477
  4. 4 Harvard University 461
  5. 5 University of Wisconsin–Madison 452

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Drug Discovery And Development.

Haarika Ayyadevara University of Arkansas
42%
Browse All 4 Researchers in Directory